Seshadri Neervannan, Chief Operating Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 8,366 shares at $76.67 ($641K) on 2026-03-04, disclosed to the SEC on 2026-03-05.
Scheduled sale ($641k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TARS | SELL | 2026-03-19 | $772K | — | Filing → |
| TARS | SELL | 2025-03-20 | $726K | — | Filing → |
| TARS | SELL | 2024-03-19 | $299K | — | Filing → |